PMID: 2125495Dec 4, 1990Paper

A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant

Biochemistry
L Zhang, F J Castellino

Abstract

Site-specific mutagenesis has been employed to alter the cDNA of human protein C (PC), such that the gamma-carboxyglutamic acid (gamma) pair at positions 6 and 7 of the recombinant (r) protein would be changed to aspartic acid residues. This variant, [gamma 6D, gamma 7D]r-PC, and its wild-type (wt) counterpart have been expressed in human kidney 293 cells. After purification, forms of wtr-PC that were fully gamma-carboxylated and beta-hydroxylated and of [gamma 6D, gamma 7D]r-PC that lacked only the two altered gamma-residues at amino acid sequence positions 6 and 7 were obtained. Subsequent to its conversion to activated PC (APC), [gamma 6D, gamma 7D]r-APC displayed a greatly reduced activity in the activated partial thromboplastin time of PC-deficient plasma, as compared to wtr-APC and human plasma APC. In addition, the activity of [gamma 6D, gamma 7D]r-APC toward inactivation of purified human factor VIII was reduced to less than 5% of that of wtr-APC and human plasma APC. These results, with the first reported mutations at gamma-residues of PC produced by recombinant DNA technology, indicate that the paired gamma-residues at positions 6 and 7, which are highly conserved in all vitamin K dependent coagulation proteins, are v...Continue Reading

Citations

Sep 1, 1993·Protein Science : a Publication of the Protein Society·R M MestersJ H Griffin
Jan 1, 1997·Protein Science : a Publication of the Protein Society·A J GaleJ H Griffin
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·W H VelanderW N Drohan
Oct 13, 1992·Annals of the New York Academy of Sciences·W H VelanderJ L Johnson
May 2, 1994·Annals of the New York Academy of Sciences·T MorcölW H Velander
Oct 28, 1998·The Journal of Clinical Investigation·L R JalbertF J Castellino
Feb 27, 2009·Blood·Laurent O MosnierJohn H Griffin
Nov 11, 2011·Thrombosis and Haemostasis·Karin C A A WildhagenGerry A F Nicolaes
Dec 10, 2009·British Journal of Haematology·Pranita P SarangiMinsoo Kim
Nov 18, 2006·Blood·Laurent O MosnierJohn H Griffin
Nov 22, 1996·The Journal of Biological Chemistry·L Zhang, E F Plow
Jun 1, 1993·International Journal of Peptide and Protein Research·T L Colpitts, F J Castellino
Jun 23, 1995·The Journal of Biological Chemistry·S Shah, D R Hyde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.